<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="Central and other publicly funded repositories, such as the WHO" exact="COVID" post="database with rights for unrestricted research re-use and analyses"/>
 <result pre="centre remains active. Highlights •Coronaviruses are RNA viruses that cause" exact="systemic" post="diseases in humans and animals. •There are no approved"/>
 <result pre="animals. •There are no approved drugs for the treatment of" exact="coronavirus infections." post="•Several SARS-CoV inhibitors, with known mechanisms of action, have"/>
 <result pre="are positive stranded RNA viruses that cause respiratory, enteric and" exact="central nervous system" post="diseases in many species, including humans. Until recently, the"/>
 <result pre="species, including humans. Until recently, the relatively low burden of" exact="disease" post="in humans caused by few of these viruses impeded"/>
 <result pre="development of coronavirus specific therapeutics. However, the emergence of severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV), and more recently, Middle East"/>
 <result pre="of coronavirus specific therapeutics. However, the emergence of severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV), and more recently, Middle East respiratory"/>
 <result pre="coronavirus specific therapeutics. However, the emergence of severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV), and more recently, Middle East respiratory syndrome"/>
 <result pre="acute respiratory syndrome coronavirus (SARS-CoV), and more recently, Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV), has impelled the development of such"/>
 <result pre="respiratory syndrome coronavirus (SARS-CoV), and more recently, Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV), has impelled the development of such drugs."/>
 <result pre="Edited by Luis Menéndez-Arias and Douglas D Richman For a" exact="complete" post="overview see the Issue and the Editorial Available online"/>
 <result pre="In September 2012, a novel coronavirus (CoV) called Middle East" exact="respiratory" post="syndrome CoV (MERS-CoV), was isolated as the causative agent"/>
 <result pre="September 2012, a novel coronavirus (CoV) called Middle East respiratory" exact="syndrome" post="CoV (MERS-CoV), was isolated as the causative agent of"/>
 <result pre="(MERS-CoV), was isolated as the causative agent of a severe" exact="pneumonia" post="in several patients in the Middle East [1]. Globally,"/>
 <result pre="of May 16, 2014, WHO has been informed of a" exact="total" post="of 614 laboratory-confirmed cases of infection with MERS-CoV (including"/>
 <result pre="been informed of a total of 614 laboratory-confirmed cases of" exact="infection" post="with MERS-CoV (including 181 deaths) primarily in the Middle"/>
 <result pre="America (http://www.who.int/csr/don/2014_05_16_mers/en/, http://www.cdc.gov/coronavirus/mers/). This CoV is closely related to severe" exact="acute" post="respiratory syndrome CoV (SARS-CoV), an epidemic that was short-lived"/>
 <result pre="(http://www.who.int/csr/don/2014_05_16_mers/en/, http://www.cdc.gov/coronavirus/mers/). This CoV is closely related to severe acute" exact="respiratory" post="syndrome CoV (SARS-CoV), an epidemic that was short-lived but"/>
 <result pre="http://www.cdc.gov/coronavirus/mers/). This CoV is closely related to severe acute respiratory" exact="syndrome" post="CoV (SARS-CoV), an epidemic that was short-lived but alarming"/>
 <result pre="mechanism produces pp1a. The polyproteins are later cleaved by two" exact="viral" post="proteinases, 3C-like protease (3CLP) and papain-like protease (PLP), to"/>
 <result pre="and papain-like protease (PLP), to yield non-structural proteins essential for" exact="viral" post="replication [3, 4]. The remaining one-third of the genome"/>
 <result pre="been reported to be transmitted to humans by aerosols through" exact="intermediate" post="hosts like palm civets infected by the virus [7,"/>
 <result pre="high fevers, indications similar to influenza, but later progresses to" exact="atypical" post="pneumonia in most cases [16]. Although, many antiviral agents"/>
 <result pre="fevers, indications similar to influenza, but later progresses to atypical" exact="pneumonia" post="in most cases [16]. Although, many antiviral agents have"/>
 <result pre="antiviral inhibitors of coronaviruses, with SARS-CoV being considered as the" exact="primary" post="virus. The inhibitors include replication and entry inhibitors, which"/>
 <result pre="first coronavirus proteins that have been studied in detail include" exact="viral" post="proteinases, namely the papain-like protease (PLP) or nsp3 and"/>
 <result pre="11 remaining downstream non-structural proteins. Hence, 3CLP is an essential" exact="viral" post="protein for the viral replication cycle, and as a"/>
 <result pre="proteins. Hence, 3CLP is an essential viral protein for the" exact="viral" post="replication cycle, and as a result becomes an attractive"/>
 <result pre="inhibiting a yet unknown novel activity of nsp3 required for" exact="viral" post="replication or may be inhibiting some cellular factors that"/>
 <result pre="viruses include nucleic acid separations [41••], the melting of highly" exact="stable" post="secondary structures within the genomic RNA in order to"/>
 <result pre="include nucleic acid separations [41••], the melting of highly stable" exact="secondary" post="structures within the genomic RNA in order to increase"/>
 <result pre="efficiency of the polyprotein [42]. Considering all these helicase functions," exact="viral" post="helicases stand as a strong antiviral target. The helicase"/>
 <result pre="SSYA10-001 was also shown to be an efficient inhibitor of" exact="viral" post="replication in a SARS-CoV replicon and live viral assays."/>
 <result pre="inhibitor of viral replication in a SARS-CoV replicon and live" exact="viral" post="assays. More recently, SSYA10-001 was shown to exhibit a"/>
 <result pre="a broad-spectrum activity against other coronaviruses, including MERS-CoV and mouse" exact="hepatitis" post="virus (MHV) [47]. Entry inhibitors Viral entry is an"/>
 <result pre="including MERS-CoV and mouse hepatitis virus (MHV) [47]. Entry inhibitors" exact="Viral" post="entry is an essential step of the virus replication"/>
 <result pre="VP-14637, which are small molecules that inhibit the entry of" exact="respiratory" post="syncytial virus by binding at a hydrophobic pocket of"/>
 <result pre="53]. Enfuvirtide and SC29EK are peptides that can also block" exact="viral" post="entry by binding to the viral transmembrane protein gp41"/>
 <result pre="that can also block viral entry by binding to the" exact="viral" post="transmembrane protein gp41 and blocking the final stage of"/>
 <result pre="and PRO140. They prevent HIV entry by binding either the" exact="viral" post="surface glycoprotein gp120 [60, 61] or the CCR5 coreceptor"/>
 <result pre="Examples of SARS-CoV entry inhibitors. The possible targets for SARS" exact="viral" post="entry, thus, include cathepsin L, ACE2–SARS-S1 interaction and S2-cell"/>
 <result pre="over others. These compounds have been shown to inhibit SARS" exact="viral" post="entry by hindering the ability of cathepsin L to"/>
 <result pre="cleave S1 from S2, thereby preventing the fusion of the" exact="viral" post="envelope with the host cell membrane, following endocytosis. Other"/>
 <result pre="envelope with the host cell membrane, following endocytosis. Other SARS" exact="viral" post="entry inhibitors include SSAA09E2 (Figure 4e), SSAA09E3 (Figure 4f),"/>
 <result pre="are small molecule compounds. SSAA09E3 [77••] prevents fusion of the" exact="viral" post="membrane with the host cellular membrane (Figure 3, Figure"/>
 <result pre="some of them are used for the treatment of some" exact="viral" post="infections, such as hepatitis C virus, albeit with some"/>
 <result pre="used for the treatment of some viral infections, such as" exact="hepatitis" post="C virus, albeit with some adverse side effects including"/>
 <result pre="hepatitis C virus, albeit with some adverse side effects including" exact="hemolytic anemia," post="elevated transaminase levels and bradycardia [83], depression, suicide, relapse"/>
 <result pre="levels and bradycardia [83], depression, suicide, relapse of drug abuse/overdose," exact="bacterial infections" post="and many others (Interferon and ribavirin treatment side effects,"/>
 <result pre="and bradycardia [83], depression, suicide, relapse of drug abuse/overdose, bacterial" exact="infections" post="and many others (Interferon and ribavirin treatment side effects,"/>
 <result pre="1ZakiA.M.van BoheemenS.BestebroerT.M.OsterhausA.D.FouchierR.A.Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi ArabiaN Engl J Med36720121814182023075143 2••RotaP.A.ObersteM.S.MonroeS.S.NixW.A.CampagnoliR.IcenogleJ.P.PenarandaS.BankampB.MaherK.ChenM.H.Characterization of a"/>
 <result pre="J Med36720121814182023075143 2••RotaP.A.ObersteM.S.MonroeS.S.NixW.A.CampagnoliR.IcenogleJ.P.PenarandaS.BankampB.MaherK.ChenM.H.Characterization of a novel coronavirus associated with severe" exact="acute" post="respiratory syndromeScience30020031394139912730500 This is the first report for the"/>
 <result pre="Med36720121814182023075143 2••RotaP.A.ObersteM.S.MonroeS.S.NixW.A.CampagnoliR.IcenogleJ.P.PenarandaS.BankampB.MaherK.ChenM.H.Characterization of a novel coronavirus associated with severe acute" exact="respiratory" post="syndromeScience30020031394139912730500 This is the first report for the complete"/>
 <result pre="acute respiratory syndromeScience30020031394139912730500 This is the first report for the" exact="complete" post="sequence of SARS-CoV complete genome with phylogenetic analyses and"/>
 <result pre="is the first report for the complete sequence of SARS-CoV" exact="complete" post="genome with phylogenetic analyses and sequence comparisons indicating its"/>
 <result pre="Biol13119953393497593163 7HonC.C.LamT.Y.ShiZ.L.DrummondA.J.YipC.W.ZengF.LamP.Y.LeungF.C.Evidence of the recombinant origin of a bat severe" exact="acute" post="respiratory syndrome (SARS)-like coronavirus and its implications on the"/>
 <result pre="7HonC.C.LamT.Y.ShiZ.L.DrummondA.J.YipC.W.ZengF.LamP.Y.LeungF.C.Evidence of the recombinant origin of a bat severe acute" exact="respiratory" post="syndrome (SARS)-like coronavirus and its implications on the direct"/>
 <result pre="of the recombinant origin of a bat severe acute respiratory" exact="syndrome" post="(SARS)-like coronavirus and its implications on the direct ancestor"/>
 <result pre="the emergence of SARSCurr Top Microbiol Immunol315200732534417848070 10HaagmansB.L.Al DhahiryS.H.ReuskenC.B.RajV.S.GalianoM.MyersR.GodekeG.J.JongesM.FaragE.DiabA.Middle East" exact="respiratory" post="syndrome coronavirus in dromedary camels: an outbreak investigationLancet Infect"/>
 <result pre="emergence of SARSCurr Top Microbiol Immunol315200732534417848070 10HaagmansB.L.Al DhahiryS.H.ReuskenC.B.RajV.S.GalianoM.MyersR.GodekeG.J.JongesM.FaragE.DiabA.Middle East respiratory" exact="syndrome" post="coronavirus in dromedary camels: an outbreak investigationLancet Infect Dis14201314014524355866"/>
 <result pre="in dromedary camels: an outbreak investigationLancet Infect Dis14201314014524355866 11Abdel-MoneimA.S.Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV): evidence and speculationsArch Virol2014 12AnnanA.BaldwinH.J.CormanV.M.KloseS.M.OwusuM.NkrumahE.E.BaduE.K.AntiP.AgbenyegaO.MeyerB.Human betacoronavirus"/>
 <result pre="dromedary camels: an outbreak investigationLancet Infect Dis14201314014524355866 11Abdel-MoneimA.S.Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV): evidence and speculationsArch Virol2014 12AnnanA.BaldwinH.J.CormanV.M.KloseS.M.OwusuM.NkrumahE.E.BaduE.K.AntiP.AgbenyegaO.MeyerB.Human betacoronavirus 2c"/>
 <result pre="BoheemenS.de GraafM.LauberC.BestebroerT.M.RajV.S.ZakiA.M.OsterhausA.D.HaagmansB.L.GorbalenyaA.E.SnijderE.J.Genomic characterization of a newly discovered coronavirus associated with" exact="acute respiratory distress syndrome" post="in humansMBio20123 15ItheteN.L.StoffbergS.CormanV.M.CottontailV.M.RichardsL.R.SchoemanM.C.DrostenC.DrexlerJ.F.PreiserW.Close relative of human Middle East respiratory"/>
 <result pre="GraafM.LauberC.BestebroerT.M.RajV.S.ZakiA.M.OsterhausA.D.HaagmansB.L.GorbalenyaA.E.SnijderE.J.Genomic characterization of a newly discovered coronavirus associated with acute" exact="respiratory" post="distress syndrome in humansMBio20123 15ItheteN.L.StoffbergS.CormanV.M.CottontailV.M.RichardsL.R.SchoemanM.C.DrostenC.DrexlerJ.F.PreiserW.Close relative of human Middle"/>
 <result pre="of a newly discovered coronavirus associated with acute respiratory distress" exact="syndrome" post="in humansMBio20123 15ItheteN.L.StoffbergS.CormanV.M.CottontailV.M.RichardsL.R.SchoemanM.C.DrostenC.DrexlerJ.F.PreiserW.Close relative of human Middle East respiratory"/>
 <result pre="distress syndrome in humansMBio20123 15ItheteN.L.StoffbergS.CormanV.M.CottontailV.M.RichardsL.R.SchoemanM.C.DrostenC.DrexlerJ.F.PreiserW.Close relative of human Middle East" exact="respiratory" post="syndrome coronavirus in bat, South AfricaEmerg Infect Dis1920131697169924050621 16PeirisJ.S.YuenK.Y.OsterhausA.D.StohrK.The"/>
 <result pre="syndrome in humansMBio20123 15ItheteN.L.StoffbergS.CormanV.M.CottontailV.M.RichardsL.R.SchoemanM.C.DrostenC.DrexlerJ.F.PreiserW.Close relative of human Middle East respiratory" exact="syndrome" post="coronavirus in bat, South AfricaEmerg Infect Dis1920131697169924050621 16PeirisJ.S.YuenK.Y.OsterhausA.D.StohrK.The severe"/>
 <result pre="syndrome coronavirus in bat, South AfricaEmerg Infect Dis1920131697169924050621 16PeirisJ.S.YuenK.Y.OsterhausA.D.StohrK.The severe" exact="acute" post="respiratory syndromeN Engl J Med34920032431244114681510 17BarnardD.L.KumakiY.Recent developments in anti-severe"/>
 <result pre="coronavirus in bat, South AfricaEmerg Infect Dis1920131697169924050621 16PeirisJ.S.YuenK.Y.OsterhausA.D.StohrK.The severe acute" exact="respiratory" post="syndromeN Engl J Med34920032431244114681510 17BarnardD.L.KumakiY.Recent developments in anti-severe acute"/>
 <result pre="acute respiratory syndromeN Engl J Med34920032431244114681510 17BarnardD.L.KumakiY.Recent developments in anti-severe" exact="acute" post="respiratory syndrome coronavirus chemotherapyFuture Virol6201161563121765859 18•LiangP.H.Characterization and inhibition of"/>
 <result pre="respiratory syndromeN Engl J Med34920032431244114681510 17BarnardD.L.KumakiY.Recent developments in anti-severe acute" exact="respiratory" post="syndrome coronavirus chemotherapyFuture Virol6201161563121765859 18•LiangP.H.Characterization and inhibition of SARS-coronavirus"/>
 <result pre="syndromeN Engl J Med34920032431244114681510 17BarnardD.L.KumakiY.Recent developments in anti-severe acute respiratory" exact="syndrome" post="coronavirus chemotherapyFuture Virol6201161563121765859 18•LiangP.H.Characterization and inhibition of SARS-coronavirus main"/>
 <result pre="of SARS-coronavirus main protease in relation to the inhibitors. 19AdedejiA.O.SinghK.CalcaterraN.E.DeDiegoM.L.EnjuanesL.WeissS.SarafianosS.G.Severe" exact="acute" post="respiratory syndrome coronavirus replication inhibitor that interferes with the"/>
 <result pre="SARS-coronavirus main protease in relation to the inhibitors. 19AdedejiA.O.SinghK.CalcaterraN.E.DeDiegoM.L.EnjuanesL.WeissS.SarafianosS.G.Severe acute" exact="respiratory" post="syndrome coronavirus replication inhibitor that interferes with the nucleic"/>
 <result pre="main protease in relation to the inhibitors. 19AdedejiA.O.SinghK.CalcaterraN.E.DeDiegoM.L.EnjuanesL.WeissS.SarafianosS.G.Severe acute respiratory" exact="syndrome" post="coronavirus replication inhibitor that interferes with the nucleic acid"/>
 <result pre="inhibitor that interferes with the nucleic acid unwinding of the" exact="viral" post="helicaseAntimicrob Agents Chemother5620124718472822733076 20AnandK.ZiebuhrJ.WadhwaniP.MestersJ.R.HilgenfeldR.Coronavirus main proteinase (3CLpro) structure: basis"/>
 <result pre="for design of anti-SARS drugsScience30020031763176712746549 21••YangH.YangM.DingY.LiuY.LouZ.ZhouZ.SunL.MoL.YeS.PangH.The crystal structures of severe" exact="acute" post="respiratory syndrome virus main protease and its complex with"/>
 <result pre="design of anti-SARS drugsScience30020031763176712746549 21••YangH.YangM.DingY.LiuY.LouZ.ZhouZ.SunL.MoL.YeS.PangH.The crystal structures of severe acute" exact="respiratory" post="syndrome virus main protease and its complex with an"/>
 <result pre="of anti-SARS drugsScience30020031763176712746549 21••YangH.YangM.DingY.LiuY.LouZ.ZhouZ.SunL.MoL.YeS.PangH.The crystal structures of severe acute respiratory" exact="syndrome" post="virus main protease and its complex with an inhibitorProc"/>
 <result pre="is the first report on the crystal structures of severe" exact="acute" post="respiratory syndrome virus main protease at different pH and"/>
 <result pre="the first report on the crystal structures of severe acute" exact="respiratory" post="syndrome virus main protease at different pH and its"/>
 <result pre="first report on the crystal structures of severe acute respiratory" exact="syndrome" post="virus main protease at different pH and its complex"/>
 <result pre="as SARS-CoV 3C-like protease inhibitorsFEBS Lett58120075454545817981158 28WuC.Y.JanJ.T.MaS.H.KuoC.J.JuanH.F.ChengY.S.HsuH.H.HuangH.C.WuD.BrikA.Small molecules targeting severe" exact="acute" post="respiratory syndrome human coronavirusProc Natl Acad Sci U S"/>
 <result pre="SARS-CoV 3C-like protease inhibitorsFEBS Lett58120075454545817981158 28WuC.Y.JanJ.T.MaS.H.KuoC.J.JuanH.F.ChengY.S.HsuH.H.HuangH.C.WuD.BrikA.Small molecules targeting severe acute" exact="respiratory" post="syndrome human coronavirusProc Natl Acad Sci U S A1012004100121001715226499"/>
 <result pre="3C-like protease inhibitorsFEBS Lett58120075454545817981158 28WuC.Y.JanJ.T.MaS.H.KuoC.J.JuanH.F.ChengY.S.HsuH.H.HuangH.C.WuD.BrikA.Small molecules targeting severe acute respiratory" exact="syndrome" post="human coronavirusProc Natl Acad Sci U S A1012004100121001715226499 29ShaoY.M.YangW.B.PengH.P.HsuM.F.TsaiK.C.KuoT.H.WangA.H.LiangP.H.LinC.H.YangA.S.Structure-based"/>
 <result pre="highly potent SARS-CoV 3CL protease inhibitorsChembiochem820071654165717722121 30ShieJ.J.FangJ.M.KuoT.H.KuoC.J.LiangP.H.HuangH.J.WuY.T.JanJ.T.ChengY.S.WongC.H.Inhibition of the severe" exact="acute" post="respiratory syndrome 3CL protease by peptidomimetic alpha,beta-unsaturated estersBioorg Med"/>
 <result pre="potent SARS-CoV 3CL protease inhibitorsChembiochem820071654165717722121 30ShieJ.J.FangJ.M.KuoT.H.KuoC.J.LiangP.H.HuangH.J.WuY.T.JanJ.T.ChengY.S.WongC.H.Inhibition of the severe acute" exact="respiratory" post="syndrome 3CL protease by peptidomimetic alpha,beta-unsaturated estersBioorg Med Chem1320055240525215994085"/>
 <result pre="SARS-CoV 3CL protease inhibitorsChembiochem820071654165717722121 30ShieJ.J.FangJ.M.KuoT.H.KuoC.J.LiangP.H.HuangH.J.WuY.T.JanJ.T.ChengY.S.WongC.H.Inhibition of the severe acute respiratory" exact="syndrome" post="3CL protease by peptidomimetic alpha,beta-unsaturated estersBioorg Med Chem1320055240525215994085 31ShieJ.J.FangJ.M.KuoC.J.KuoT.H.LiangP.H.HuangH.J.YangW.B.LinC.H.ChenJ.L.WuY.T.Discovery"/>
 <result pre="Med Chem1320055240525215994085 31ShieJ.J.FangJ.M.KuoC.J.KuoT.H.LiangP.H.HuangH.J.YangW.B.LinC.H.ChenJ.L.WuY.T.Discovery of potent anilide inhibitors against the severe" exact="acute" post="respiratory syndrome 3CL proteaseJ Med Chem4820054469447315974598 32WuC.Y.KingK.Y.KuoC.J.FangJ.M.WuY.T.HoM.Y.LiaoC.L.ShieJ.J.LiangP.H.WongC.H.Stable benzotriazole esters"/>
 <result pre="Chem1320055240525215994085 31ShieJ.J.FangJ.M.KuoC.J.KuoT.H.LiangP.H.HuangH.J.YangW.B.LinC.H.ChenJ.L.WuY.T.Discovery of potent anilide inhibitors against the severe acute" exact="respiratory" post="syndrome 3CL proteaseJ Med Chem4820054469447315974598 32WuC.Y.KingK.Y.KuoC.J.FangJ.M.WuY.T.HoM.Y.LiaoC.L.ShieJ.J.LiangP.H.WongC.H.Stable benzotriazole esters as"/>
 <result pre="31ShieJ.J.FangJ.M.KuoC.J.KuoT.H.LiangP.H.HuangH.J.YangW.B.LinC.H.ChenJ.L.WuY.T.Discovery of potent anilide inhibitors against the severe acute respiratory" exact="syndrome" post="3CL proteaseJ Med Chem4820054469447315974598 32WuC.Y.KingK.Y.KuoC.J.FangJ.M.WuY.T.HoM.Y.LiaoC.L.ShieJ.J.LiangP.H.WongC.H.Stable benzotriazole esters as mechanism-based"/>
 <result pre="Chem4820054469447315974598 32WuC.Y.KingK.Y.KuoC.J.FangJ.M.WuY.T.HoM.Y.LiaoC.L.ShieJ.J.LiangP.H.WongC.H.Stable benzotriazole esters as mechanism-based inactivators of the severe" exact="acute" post="respiratory syndrome 3CL proteaseChem Biol13200626126816638531 33TsaiK.C.ChenS.Y.LiangP.H.LuI.L.MahindrooN.HsiehH.P.ChaoY.S.LiuL.LiuD.LienW.Discovery of a novel"/>
 <result pre="32WuC.Y.KingK.Y.KuoC.J.FangJ.M.WuY.T.HoM.Y.LiaoC.L.ShieJ.J.LiangP.H.WongC.H.Stable benzotriazole esters as mechanism-based inactivators of the severe acute" exact="respiratory" post="syndrome 3CL proteaseChem Biol13200626126816638531 33TsaiK.C.ChenS.Y.LiangP.H.LuI.L.MahindrooN.HsiehH.P.ChaoY.S.LiuL.LiuD.LienW.Discovery of a novel family"/>
 <result pre="benzotriazole esters as mechanism-based inactivators of the severe acute respiratory" exact="syndrome" post="3CL proteaseChem Biol13200626126816638531 33TsaiK.C.ChenS.Y.LiangP.H.LuI.L.MahindrooN.HsiehH.P.ChaoY.S.LiuL.LiuD.LienW.Discovery of a novel family of"/>
 <result pre="Chem4920063485349516759091 34LuI.L.HuangC.F.PengY.H.LinY.T.HsiehH.P.ChenC.T.LienT.W.LeeH.J.MahindrooN.PrakashE.Structure-based drug design of a novel family of PPARgamma" exact="partial" post="agonists: virtual screening, X-ray crystallography, and in vitro/in vivo"/>
 <result pre="of SARS-CoV 3CL proteaseBioorg Med Chem Lett2020103569357220494577 37HarcourtB.H.JuknelieneD.KanjanahaluethaiA.BechillJ.SeversonK.M.SmithC.M.RotaP.A.BakerS.C.Identification of severe" exact="acute" post="respiratory syndrome coronavirus replicase products and characterization of papain-like"/>
 <result pre="SARS-CoV 3CL proteaseBioorg Med Chem Lett2020103569357220494577 37HarcourtB.H.JuknelieneD.KanjanahaluethaiA.BechillJ.SeversonK.M.SmithC.M.RotaP.A.BakerS.C.Identification of severe acute" exact="respiratory" post="syndrome coronavirus replicase products and characterization of papain-like protease"/>
 <result pre="3CL proteaseBioorg Med Chem Lett2020103569357220494577 37HarcourtB.H.JuknelieneD.KanjanahaluethaiA.BechillJ.SeversonK.M.SmithC.M.RotaP.A.BakerS.C.Identification of severe acute respiratory" exact="syndrome" post="coronavirus replicase products and characterization of papain-like protease activityJ"/>
 <result pre="of papain-like protease activityJ Virol782004136001361215564471 38BarrettoN.JuknelieneD.RatiaK.ChenZ.MesecarA.D.BakerS.C.The papain-like protease of severe" exact="acute" post="respiratory syndrome coronavirus has deubiquitinating activityJ Virol792005151891519816306590 39FriemanM.BasuD.MatthewsK.TaylorJ.JonesG.PicklesR.BaricR.EngelD.A.Yeast based"/>
 <result pre="papain-like protease activityJ Virol782004136001361215564471 38BarrettoN.JuknelieneD.RatiaK.ChenZ.MesecarA.D.BakerS.C.The papain-like protease of severe acute" exact="respiratory" post="syndrome coronavirus has deubiquitinating activityJ Virol792005151891519816306590 39FriemanM.BasuD.MatthewsK.TaylorJ.JonesG.PicklesR.BaricR.EngelD.A.Yeast based small"/>
 <result pre="protease activityJ Virol782004136001361215564471 38BarrettoN.JuknelieneD.RatiaK.ChenZ.MesecarA.D.BakerS.C.The papain-like protease of severe acute respiratory" exact="syndrome" post="coronavirus has deubiquitinating activityJ Virol792005151891519816306590 39FriemanM.BasuD.MatthewsK.TaylorJ.JonesG.PicklesR.BaricR.EngelD.A.Yeast based small molecule"/>
 <result pre="nuclei acid unwinding by SARS-CoV helicase. 42PaoliniC.De FrancescoR.GallinariP.Enzymatic properties of" exact="hepatitis" post="C virus NS3-associated helicaseJ Gen Virol8120001335134510769077 43KimM.K.YuM.S.ParkH.R.KimK.B.LeeC.ChoS.Y.KangJ.YoonH.KimD.E.ChooH.2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral"/>
 <result pre="NS3-associated helicaseJ Gen Virol8120001335134510769077 43KimM.K.YuM.S.ParkH.R.KimK.B.LeeC.ChoS.Y.KangJ.YoonH.KimD.E.ChooH.2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both" exact="hepatitis" post="C virus (HCV) and SARS-associated coronavirus (SCV)Eur J Med"/>
 <result pre="SARS coronavirusChem Biol12200530331115797214 46AdedejiA.O.SarafianosS.G.Future treatment strategies for novel Middle East" exact="respiratory" post="syndrome coronavirus infectionFuture Med Chem520132119212224261888 47AdedejiA.O.SinghK.KassimA.ColemanC.M.ElliottR.WeissS.R.FriemanM.B.SarafianosS.G.Evaluation of SSYA10-001 as"/>
 <result pre="coronavirusChem Biol12200530331115797214 46AdedejiA.O.SarafianosS.G.Future treatment strategies for novel Middle East respiratory" exact="syndrome" post="coronavirus infectionFuture Med Chem520132119212224261888 47AdedejiA.O.SinghK.KassimA.ColemanC.M.ElliottR.WeissS.R.FriemanM.B.SarafianosS.G.Evaluation of SSYA10-001 as a"/>
 <result pre="and MERS coronavirusesAntimicrob Agents Chemother588201410.1128/AAC.02994-14PMID: 24841268 48BuppK.RothM.J.Alteration and analyses of" exact="viral" post="entry with library-derived peptidesAdv Virus Res65200514717216387196 49DouglasJ.L.PanisM.L.HoE.LinK.Y.KrawczykS.H.GrantD.M.CaiR.SwaminathanS.CihlarT.Inhibition of respiratory"/>
 <result pre="of viral entry with library-derived peptidesAdv Virus Res65200514717216387196 49DouglasJ.L.PanisM.L.HoE.LinK.Y.KrawczykS.H.GrantD.M.CaiR.SwaminathanS.CihlarT.Inhibition of" exact="respiratory" post="syncytial virus fusion by the small molecule VP-14637 via"/>
 <result pre="specific interactions with F proteinJ Virol7720035054506412692208 50RazinkovV.GazumyanA.NikitenkoA.EllestadG.KrishnamurthyG.RFI-641 inhibits entry of" exact="respiratory" post="syncytial virus via interactions with fusion proteinChem Biol8200164565911451666 51Lieberman-BlumS.S.FungH.B.BandresJ.C.Maraviroc:"/>
 <result pre="receptor antagonist, UK-427,857, a new agent for the treatment of" exact="HIV infection" post="and AIDSProg Med Chem43200523927115850827 54AnonymousPentafuside. DP 178, T 20Drugs"/>
 <result pre="antagonist, UK-427,857, a new agent for the treatment of HIV" exact="infection" post="and AIDSProg Med Chem43200523927115850827 54AnonymousPentafuside. DP 178, T 20Drugs"/>
 <result pre="future for antiviral fusion inhibitors?Curr Opin Virol22012505922440966 56DerdeynC.A.DeckerJ.M.SfakianosJ.N.WuX.O’BrienW.A.RatnerL.KappesJ.C.ShawG.M.HunterE.Sensitivity of human" exact="immunodeficiency" post="virus type 1 to the fusion inhibitor T-20 is"/>
 <result pre="antiviral fusion inhibitors?Curr Opin Virol22012505922440966 56DerdeynC.A.DeckerJ.M.SfakianosJ.N.WuX.O’BrienW.A.RatnerL.KappesJ.C.ShawG.M.HunterE.Sensitivity of human immunodeficiency virus" exact="type 1" post="to the fusion inhibitor T-20 is modulated by coreceptor"/>
 <result pre="peptide fusion inhibitor with enhanced alpha-helicity, inhibits replication of human" exact="immunodeficiency" post="virus type 1 mutants resistant to enfuvirtideAntimicrob Agents Chemother5320091013101819114674"/>
 <result pre="inhibitor with enhanced alpha-helicity, inhibits replication of human immunodeficiency virus" exact="type 1" post="mutants resistant to enfuvirtideAntimicrob Agents Chemother5320091013101819114674 60EdaY.MurakamiT.AmiY.NakasoneT.TakizawaM.SomeyaK.KaizuM.IzumiY.YoshinoN.MatsushitaS.Anti-V3 humanized antibody"/>
 <result pre="humanized antibody KD-247 effectively suppresses ex vivo generation of human" exact="immunodeficiency" post="virus type 1 and affords sterile protection of monkeys"/>
 <result pre="KD-247 effectively suppresses ex vivo generation of human immunodeficiency virus" exact="type 1" post="and affords sterile protection of monkeys against a heterologous"/>
 <result pre="and affords sterile protection of monkeys against a heterologous simian/human" exact="immunodeficiency" post="virus infectionJ Virol8020065563557016699037 61MatsushitaS.TakahamaS.ShibataJ.KimuraT.ShiozakiK.EdaY.KoitoA.MurakamiT.YoshimuraK.Ex vivo neutralization of HIV-1 quasi-species"/>
 <result pre="humanized monoclonal antibody KD-247Hum Antibodies142005818816720978 62CilliersT.WilleyS.SullivanW.M.PatienceT.PugachP.CoetzerM.PapathanasopoulosM.MooreJ.P.TrkolaA.ClaphamP.Use of alternate coreceptors on" exact="primary" post="cells by two HIV-1 isolatesVirology339200513614415992849 63DauB.HolodniyM.Novel targets for antiretroviral"/>
 <result pre="fusion core complexJ Virol7720038801881112885899 66HofmannH.GeierM.MarziA.KrumbiegelM.PeippM.FeyG.H.GrambergT.PohlmannS.Susceptibility to SARS coronavirus S protein-driven" exact="infection" post="correlates with expression of angiotensin converting enzyme 2 and"/>
 <result pre="infection correlates with expression of angiotensin converting enzyme 2 and" exact="infection" post="can be blocked by soluble receptorBiochem Biophys Res Commun31920041216122115194496"/>
 <result pre="receptorBiochem Biophys Res Commun31920041216122115194496 67••SimmonsG.GosaliaD.N.RennekampA.J.ReevesJ.D.DiamondS.L.BatesP.Inhibitors of cathepsin L prevent severe" exact="acute" post="respiratory syndrome coronavirus entryProc Natl Acad Sci U S"/>
 <result pre="Biophys Res Commun31920041216122115194496 67••SimmonsG.GosaliaD.N.RennekampA.J.ReevesJ.D.DiamondS.L.BatesP.Inhibitors of cathepsin L prevent severe acute" exact="respiratory" post="syndrome coronavirus entryProc Natl Acad Sci U S A1022005118761188116081529"/>
 <result pre="Res Commun31920041216122115194496 67••SimmonsG.GosaliaD.N.RennekampA.J.ReevesJ.D.DiamondS.L.BatesP.Inhibitors of cathepsin L prevent severe acute respiratory" exact="syndrome" post="coronavirus entryProc Natl Acad Sci U S A1022005118761188116081529 First"/>
 <result pre="within the SARS-CoV envelope. 70YangZ.Y.HuangY.GaneshL.LeungK.KongW.P.SchwartzO.SubbaraoK.Nabel GJ: pH-dependent entry of severe" exact="acute" post="respiratory syndrome coronavirus is mediated by the spike glycoprotein"/>
 <result pre="the SARS-CoV envelope. 70YangZ.Y.HuangY.GaneshL.LeungK.KongW.P.SchwartzO.SubbaraoK.Nabel GJ: pH-dependent entry of severe acute" exact="respiratory" post="syndrome coronavirus is mediated by the spike glycoprotein and"/>
 <result pre="SARS-CoV envelope. 70YangZ.Y.HuangY.GaneshL.LeungK.KongW.P.SchwartzO.SubbaraoK.Nabel GJ: pH-dependent entry of severe acute respiratory" exact="syndrome" post="coronavirus is mediated by the spike glycoprotein and enhanced"/>
 <result pre="73ShahP.P.WangT.KaletskyR.L.MyersM.C.PurvisJ.E.JingH.HurynD.M.GreenbaumD.C.SmithA.B.IIIBatesP.A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe" exact="acute" post="respiratory syndrome and ebola pseudotype virus infection into human"/>
 <result pre="small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute" exact="respiratory" post="syndrome and ebola pseudotype virus infection into human embryonic"/>
 <result pre="oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory" exact="syndrome" post="and ebola pseudotype virus infection into human embryonic kidney"/>
 <result pre="cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype" exact="virus infection" post="into human embryonic kidney 293T cellsMol Pharmacol78201031932420466822 74StruckA.W.AxmannM.PfefferleS.DrostenC.MeyerB.A hexapeptide"/>
 <result pre="L blocks severe acute respiratory syndrome and ebola pseudotype virus" exact="infection" post="into human embryonic kidney 293T cellsMol Pharmacol78201031932420466822 74StruckA.W.AxmannM.PfefferleS.DrostenC.MeyerB.A hexapeptide"/>
 <result pre="the receptor-binding domain of SARS corona virus spike protein blocks" exact="viral" post="entry into host cells via the human receptor ACE2Antiviral"/>
 <result pre="an internally-controlled dual envelope pseudovirion assayAntiviral Res92201118719421820471 76••SimmonsG.ReevesJ.D.RennekampA.J.AmbergS.M.PieferA.J.BatesP.Characterization of severe" exact="acute" post="respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entryProc Natl"/>
 <result pre="internally-controlled dual envelope pseudovirion assayAntiviral Res92201118719421820471 76••SimmonsG.ReevesJ.D.RennekampA.J.AmbergS.M.PieferA.J.BatesP.Characterization of severe acute" exact="respiratory" post="syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entryProc Natl Acad"/>
 <result pre="76••SimmonsG.ReevesJ.D.RennekampA.J.AmbergS.M.PieferA.J.BatesP.Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated" exact="viral" post="entryProc Natl Acad Sci U S A10120044240424515010527 Development of"/>
 <result pre="A10120044240424515010527 Development of SARS-pseudotyped virus to study the mechanism of" exact="viral" post="entry and possible antiviral targets. 77••AdedejiA.O.SeversonW.JonssonC.SinghK.WeissS.R.SarafianosS.G.Novel inhibitors of severe"/>
 <result pre="viral entry and possible antiviral targets. 77••AdedejiA.O.SeversonW.JonssonC.SinghK.WeissS.R.SarafianosS.G.Novel inhibitors of severe" exact="acute" post="respiratory syndrome coronavirus entry that act by three distinct"/>
 <result pre="entry and possible antiviral targets. 77••AdedejiA.O.SeversonW.JonssonC.SinghK.WeissS.R.SarafianosS.G.Novel inhibitors of severe acute" exact="respiratory" post="syndrome coronavirus entry that act by three distinct mechanismsJ"/>
 <result pre="and possible antiviral targets. 77••AdedejiA.O.SeversonW.JonssonC.SinghK.WeissS.R.SarafianosS.G.Novel inhibitors of severe acute respiratory" exact="syndrome" post="coronavirus entry that act by three distinct mechanismsJ Virol8720138017802823678171"/>
 <result pre="SARS-CoV entry into permissive cells. 80DanilczykU.PenningerJ.M.Angiotensin-converting enzyme II in the" exact="heart" post="and the kidneyCirc Res98200646347116514079 81PeirisJ.S.ChuC.M.ChengV.C.ChanK.S.HungI.F.PoonL.L.LawK.I.TangB.S.HonT.Y.ChanC.S.Clinical progression and viral load"/>
 <result pre="in the heart and the kidneyCirc Res98200646347116514079 81PeirisJ.S.ChuC.M.ChengV.C.ChanK.S.HungI.F.PoonL.L.LawK.I.TangB.S.HonT.Y.ChanC.S.Clinical progression and" exact="viral" post="load in a community outbreak of coronavirus-associated SARS pneumonia:"/>
 <result pre="community outbreak of coronavirus-associated SARS pneumonia: a prospective studyLancet36120031767177212781535 82SungJ.J.WuA.JoyntG.M.YuenK.Y.LeeN.ChanP.K.CockramC.S.AhujaA.T.YuL.M.WongV.W.Severe" exact="acute" post="respiratory syndrome: report of treatment and outcome after a"/>
 <result pre="outbreak of coronavirus-associated SARS pneumonia: a prospective studyLancet36120031767177212781535 82SungJ.J.WuA.JoyntG.M.YuenK.Y.LeeN.ChanP.K.CockramC.S.AhujaA.T.YuL.M.WongV.W.Severe acute" exact="respiratory" post="syndrome: report of treatment and outcome after a major"/>
 <result pre="the greater Toronto areaJAMA28920032801280912734147 84LoutfyM.R.BlattL.M.SiminovitchK.A.WardS.WolffB.LhoH.PhamD.H.DeifH.LaMereE.A.ChangM.Interferon alfacon-1 plus corticosteroids in severe" exact="acute" post="respiratory syndrome: a preliminary studyJAMA29020033222322814693875 85ChuC.M.ChengV.C.HungI.F.WongM.M.ChanK.H.ChanK.S.KaoR.Y.PoonL.L.WongC.L.GuanY.Role of lopinavir/ritonavir in"/>
 <result pre="greater Toronto areaJAMA28920032801280912734147 84LoutfyM.R.BlattL.M.SiminovitchK.A.WardS.WolffB.LhoH.PhamD.H.DeifH.LaMereE.A.ChangM.Interferon alfacon-1 plus corticosteroids in severe acute" exact="respiratory" post="syndrome: a preliminary studyJAMA29020033222322814693875 85ChuC.M.ChengV.C.HungI.F.WongM.M.ChanK.H.ChanK.S.KaoR.Y.PoonL.L.WongC.L.GuanY.Role of lopinavir/ritonavir in the"/>
 <result pre="We also acknowledge support from Ministry of Knowledge and Economy," exact="Bilateral" post="International Collaborative R&amp;amp;D Program, Republic of Korea."/>
</results>
